14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $50.35 $57.15 Thursday, 2nd May 2024 INCY stock ended at $53.09. This is 0.283% more than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 2.26% from a day low at $52.28 to a day high of $53.46.
90 days $50.35 $61.87
52 weeks $50.27 $67.72

Historical Incyte Corporation prices

Date Open High Low Close Volume
Jun 09, 2023 $61.34 $61.76 $60.73 $61.04 1 493 279
Jun 08, 2023 $61.50 $61.75 $60.95 $61.51 1 250 169
Jun 07, 2023 $61.58 $61.90 $61.01 $61.39 1 559 662
Jun 06, 2023 $62.65 $62.74 $61.41 $61.71 1 887 096
Jun 05, 2023 $62.36 $62.90 $62.18 $62.37 1 347 571
Jun 02, 2023 $61.50 $62.60 $61.42 $62.54 1 753 196
Jun 01, 2023 $61.59 $61.90 $60.71 $61.51 1 693 314
May 31, 2023 $61.92 $62.44 $61.41 $61.55 3 915 740
May 30, 2023 $62.21 $62.71 $61.32 $61.87 1 252 883
May 26, 2023 $62.65 $63.00 $62.33 $62.58 1 278 489
May 25, 2023 $63.66 $63.73 $62.48 $62.87 1 552 845
May 24, 2023 $64.80 $65.13 $64.27 $64.28 1 379 933
May 23, 2023 $64.36 $65.96 $64.36 $65.08 1 761 530
May 22, 2023 $63.94 $64.68 $63.43 $64.39 1 301 662
May 19, 2023 $63.80 $64.34 $63.33 $63.57 1 826 392
May 18, 2023 $64.57 $64.75 $63.06 $63.63 1 308 786
May 17, 2023 $64.65 $64.73 $63.58 $64.55 1 131 752
May 16, 2023 $65.72 $65.77 $64.68 $64.70 1 225 313
May 15, 2023 $65.50 $66.24 $65.30 $66.20 1 378 516
May 12, 2023 $64.20 $65.41 $64.19 $65.28 1 211 472
May 11, 2023 $64.11 $64.19 $63.48 $64.17 1 408 734
May 10, 2023 $64.96 $65.01 $63.84 $63.92 1 789 657
May 09, 2023 $65.39 $65.70 $64.62 $64.77 1 508 603
May 08, 2023 $66.58 $66.62 $65.49 $65.79 1 214 250
May 05, 2023 $66.75 $67.72 $65.64 $66.56 1 472 883
Click to get the best stock tips daily for free!

About Incyte Corporation

Incyte Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as oncogenic drivers in various liquid and solid tumor types; and ICLUSIG, a kinase inhibitor to treat chr... INCY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT